Cargando…
Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction
BACKGROUND: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well cha...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640574/ https://www.ncbi.nlm.nih.gov/pubmed/34901801 http://dx.doi.org/10.1016/j.cjco.2021.06.007 |
_version_ | 1784609359877111808 |
---|---|
author | Luo, Nancy O'Connor, Christopher M. Chiswell, Karen Anstrom, Kevin J. Newby, L. Kristin Mentz, Robert J. |
author_facet | Luo, Nancy O'Connor, Christopher M. Chiswell, Karen Anstrom, Kevin J. Newby, L. Kristin Mentz, Robert J. |
author_sort | Luo, Nancy |
collection | PubMed |
description | BACKGROUND: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well characterized for HF without CHD. We investigated the characteristics and 5-year mortality outcomes among patients with HF without significant CHD, stratified by EF. METHODS: Patients with clinical heart failure who underwent coronary angiography at Duke University Medical Center from 1996 through 2009 and had no significant CHD with EF ≤ 40% were compared with patients without significant CHD with EF > 40%. Survival was examined using Kaplan-Meier methods and multivariable Cox proportional hazards modeling. Analyses were repeated using EF ≥ 50%. RESULTS: Of 3154 patients with HF without significant CHD, 1530 (48.5%) had HFpEF (EF > 40%). These patients were older and more likely to have a Charlson Index ≥ 2 than patients with reduced EF. Patients with HFpEF had a lower risk of death than those with reduced EF (unadjusted hazard ratio [HR] 0.85; 95% confidence interval [CI] 0.74-0.99). From 1996 through 2009, the secular trend of death decreased among patients without CHD and with reduced EF (HR 0.92; 95% CI 0.88-0.97) but not among those with preserved EF (HR 0.99; 95% CI 0.93-1.05; P interaction 0.095). No finding was significant after multivariable risk adjustment. Results were consistent when defining preserved EF as EF ≥ 50%. CONCLUSIONS: Among patients without significant CHD, those with HFpEF had similar risks of 5-year mortality as patients with HF with reduced ejection fraction. |
format | Online Article Text |
id | pubmed-8640574 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-86405742021-12-09 Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction Luo, Nancy O'Connor, Christopher M. Chiswell, Karen Anstrom, Kevin J. Newby, L. Kristin Mentz, Robert J. CJC Open Original Article BACKGROUND: Prior studies suggest similar long-term mortality rates for patients with heart failure (HF) with preserved ejection fraction (HFpEF) vs reduced ejection fraction. However, although coronary heart disease (CHD) is associated with worse prognosis in HF, clinical outcomes are less well characterized for HF without CHD. We investigated the characteristics and 5-year mortality outcomes among patients with HF without significant CHD, stratified by EF. METHODS: Patients with clinical heart failure who underwent coronary angiography at Duke University Medical Center from 1996 through 2009 and had no significant CHD with EF ≤ 40% were compared with patients without significant CHD with EF > 40%. Survival was examined using Kaplan-Meier methods and multivariable Cox proportional hazards modeling. Analyses were repeated using EF ≥ 50%. RESULTS: Of 3154 patients with HF without significant CHD, 1530 (48.5%) had HFpEF (EF > 40%). These patients were older and more likely to have a Charlson Index ≥ 2 than patients with reduced EF. Patients with HFpEF had a lower risk of death than those with reduced EF (unadjusted hazard ratio [HR] 0.85; 95% confidence interval [CI] 0.74-0.99). From 1996 through 2009, the secular trend of death decreased among patients without CHD and with reduced EF (HR 0.92; 95% CI 0.88-0.97) but not among those with preserved EF (HR 0.99; 95% CI 0.93-1.05; P interaction 0.095). No finding was significant after multivariable risk adjustment. Results were consistent when defining preserved EF as EF ≥ 50%. CONCLUSIONS: Among patients without significant CHD, those with HFpEF had similar risks of 5-year mortality as patients with HF with reduced ejection fraction. Elsevier 2021-06-17 /pmc/articles/PMC8640574/ /pubmed/34901801 http://dx.doi.org/10.1016/j.cjco.2021.06.007 Text en © 2021 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Article Luo, Nancy O'Connor, Christopher M. Chiswell, Karen Anstrom, Kevin J. Newby, L. Kristin Mentz, Robert J. Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction |
title | Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction |
title_full | Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction |
title_fullStr | Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction |
title_full_unstemmed | Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction |
title_short | Survival in Patients With Nonischemic Cardiomyopathy With Preserved vs Reduced Ejection Fraction |
title_sort | survival in patients with nonischemic cardiomyopathy with preserved vs reduced ejection fraction |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640574/ https://www.ncbi.nlm.nih.gov/pubmed/34901801 http://dx.doi.org/10.1016/j.cjco.2021.06.007 |
work_keys_str_mv | AT luonancy survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction AT oconnorchristopherm survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction AT chiswellkaren survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction AT anstromkevinj survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction AT newbylkristin survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction AT mentzrobertj survivalinpatientswithnonischemiccardiomyopathywithpreservedvsreducedejectionfraction |